|Bid||72.00 x 500|
|Ask||77.35 x 100|
|Day's Range||73.98 - 76.99|
|52 Week Range||25.50 - 99.45|
|PE Ratio (TTM)||-8.64|
|Earnings Date||Nov 1, 2017 - Nov 6, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||93.73|
Clovis Oncology (CLVS) was a big mover last session, as the company saw its shares rise nearly 11% on the day amid huge volumes.
NEW YORK, NY / ACCESSWIRE / September 19, 2017 / Dimension Therapeutics and Clovis Oncology both saw big gains on Monday. It was takeover buzz that set Clovis shares moving north while Dimension soared ...
Last month, Todd Hagopian named Clovis Oncology as 1 of 3 takeover candidates. Today CLVS is trading around $76, up more than 10% on double its' normal daily volume making it the third largest position in Todd's Biotech fund.